Paul Miller

5PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 03, 2023
p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer.

Paul Miller, Elliot H Akama-Garren, Richard P Owen

|Feb 06, 2023
Regulation of immunological tolerance by the p53-inhibitor iASPP.

Elliot H Akama-Garren, Paul Miller, Thomas M Carroll

|Nov 20, 2018
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells.

Joshua D Freedman, Margaret R Duffy, Janet Lei-Rossmann

Pageof 1